By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: U.S. Drug Shortage Crisis Creates Greater Health Risks
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Health > U.S. Drug Shortage Crisis Creates Greater Health Risks
HealthMedicines

U.S. Drug Shortage Crisis Creates Greater Health Risks

The drug shortage is threatening our health, which needs to be a priority for the next president.

Abby Norman
Abby Norman
Share
6 Min Read
DepositPhotos r ColleenMichaels
SHARE

You probably take medication for granted. This isn’t because you don’t rely on it. You probably do. Over 131 million people take some prescription drugs. That is 66% of all adults in the United States.

Contents
  • The Current Landscape
  • Federal Attention and Proposed Solutions
  • Proposed Solutions for the Next President

The reason that you don’t worry too much about medication is that you figure that it will always be there when you need it, as long as you have insurance. Sadly, this isn’t the case.

There is a growing drug shortage in the United States, which is threatening our health. A couple of years ago, we talked about how more kids had access to prescription medication, which as a good thing. Unfortunately, that is not longer the case as the drug shortage makes it harder than ever for people to access medication.

Drug shortages in the United States have affected hospitals and retail pharmacies, eventually trickling down to patient care. Reports say these shortages are worse than ever, hitting record numbers, and gaining increasing federal attention. As the next president prepares to tackle this serious problem, it’s important to understand where things stand in the current state of drug shortages, their causes, and the actionable steps that would alleviate this crisis.

More Read

UV damage to eyes
Warning Signs of Long-Term UV Damage to Your Eyes
Understanding Plantar Fasciitis: Causes, Symptoms, Prevention, And Treatment Options
Chewing Matters More Than You Think: Why Proper Chewing Supports Better Health
5 Things to Do If You Suspect Medical Malpractice
Dietary Supplements: What Are They And Their Benefits?

The Current Landscape

A few analysts published a study in IPD Analytics titled Legislation & Government Insights. Drug Shortages: Legislation and Proposed Regulatory Actions which  tracked a record 323 active drug shortages in the first quarter of 2024. That is the highest number on record, surpassing the previous record of 320 active drug shortages set back in 2014. Many of the shortages are critical medications and have been driven by persistent supply chain problems and financial pressure on manufacturers.

The FDA and ASHP are the two primary sources that track these shortages. While the FDA derives its information from manufacturers, the ASHP does so from voluntary reports by practitioners, patients, and other stakeholders. Because of these differences in sources, the number of shortages reported by the FDA and ASHP often differs, but the overall picture remains grim.

The FDA will release its 11th annual Report on Drug Shortages to Congress in June 2024, outlining the challenges experienced during 2023. Manufacturers’ quality, capacity issues, and unexpected events such as facility closures and natural disasters were key challenges. These, coupled with increasing demand for some drugs, put additional stress on the supply chain.

Federal Attention and Proposed Solutions

There is now immense attention to the drug shortage crisis at the federal level, including proposed federal programs and legislative efforts designed to address the issue. For instance, the White House Council on Supply Chain Resilience has helped create a new position within HHS dedicated to supply chain resilience and shortage coordination. Moreover, under the events occurring in 2024, the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines, or the PREPARE Act, will necessitate a director to oversee a strategic reserve of pharmaceutical ingredients.

Furthermore, investigations on the matter are also being conducted by the U.S. Federal Trade Commission. All these developments simply point to the fact that drug shortages are not only serious but highly complicated problems.

Proposed Solutions for the Next President

It is an election year, which means that both presidential candidates will have to tackle healthcare issues. Most discussions center around reigning in spending, but dealing with the drug shortage will also be vital. The new president must look towards a multi-faceted approach that shall include both short- and long-term strategies to cover effectively the crisis of drug shortage:

Invest in Domestic Manufacturing: Encourage the growth of domestic pharmaceutical manufacturing to decrease reliance on foreign suppliers. Domestic production will help to have a stable supply of vital medications and a reduction of vulnerability to global disruptions.

Regulatory Reforms: Simplify and expedite the FDA approval processes for generic drugs and alternative treatments. By reducing bureaucratic hurdles, the government can facilitate a quicker response to shortages and increase the availability of critical medications.

Centralized Federal Leadership: Assist in establishing a central leadership role in the federal government over the drug supply chain. This means coordinating leading efforts from agencies and sectors to help solve supply chain issues, manage shortages, and ensure adequate and stable supply of key drugs.

The drug shortage should be one of the first orders of business for the next president, provided with a far-reaching strategy of domestic production, streamlining of the regulatory process, and centralized leadership. By this, the administration can work toward ensuring the reliable availability of essential medications to ensure the health and well-being of American citizens.

TAGGED:health risksmedicine shortage
Share This Article
Facebook Copy Link Print
Share
By Abby Norman
My name is Abby Norman and I am a healthcare blogger. With over 10 years of experience in the medical field, I have developed a passion for helping others understand the complexities of healthcare.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Everything you need to know about hyaluronic acid treatment
FitnessHealth

Everything you need to know about hyaluronic acid treatment

February 7, 2022
Temperature Control in Hospitals: The Intersection of Comfort and Medical Efficiency
Health

Temperature Control in Hospitals: The Intersection of Comfort and Medical Efficiency

January 17, 2025
Healthcare,Providers,In,An,Office,Setting.
Health

From Patients to Partners: Empowering a Healthier Society

March 28, 2024
health issues
Health

How To Overcome The Financial Impacts Of Health Issues With Home Equity

December 23, 2022
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?